Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
about
Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET ImagingIn vivo PET imaging of neuroinflammation in Alzheimer's disease.Endocannabinoid system in neurodegenerative disorders.The emerging role of PET imaging in dementia.Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor.Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands.Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
P2860
Q36364053-33BCCB20-937B-4BEF-BE96-6DB04E43D78BQ38779574-B11F10CC-7DD1-43C2-A69A-5C37B8BD1254Q39368845-7E45A9ED-AE6F-4BF0-8900-75B03C83CEE8Q42701971-612CBB91-51D6-4DAE-AFEE-9DAA48893990Q47432979-38BD3245-B1B0-4EF7-9C39-0AAE310C37F4Q47566341-792F242C-8ABB-4A1C-BE9A-F06F2EEE7F36Q48110956-134FC456-DB10-4084-8E51-FC6E350AC6CDQ54462296-5E885D9F-67FE-4AB0-B233-C016F69F4328Q58751451-8CC89437-1B2A-4698-8977-90AAED2A98E4
P2860
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@en
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@nl
type
label
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@en
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@nl
prefLabel
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@en
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@nl
P2093
P2860
P921
P1476
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
@en
P2093
Andrey Postnov
Guy Bormans
Koen Van Laere
Mathieu Vandenbulcke
Rawaha Ahmad
P2860
P2888
P304
P356
10.1007/S00259-016-3457-7
P50
P577
2016-08-03T00:00:00Z